Assessment System of Sarcopenia in Lung Cancer Patients
Recruiting now
Conditions studied: Sarcopenia, Lung Cancer, Ultrasound
In brief
1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.
Key facts
- Study ID
- NCT06327594
- Run by
- West China Hospital
- People needed
- 1500
- Starts
- 2023-11-01
- Expected to finish
- 2028-11-01
- Last updated by the study team
- 2024-03-25
Who can join
Age: 40 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Hospitalized patients scheduled for radical resection of lung cancer.
- With a CT/MRI examination within 1 week.
- The compliance of examination was good.
You may not qualify if…
- Amputated arm or leg.
- Severe oedema (oedema higher than knee level).
- Implantable pacemaker.
- Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.
Where it is running
- Xinyi Tang — Chengdu, Sichuan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.